Literature DB >> 12941482

Characterisation of mouse monoclonal antibodies for pneumolysin: fine epitope mapping and V gene usage.

Beatriz Suárez-Alvarez1, María del Mar García-Suárez, Francisco J Méndez, Juan R de los Toyos.   

Abstract

Pneumolysin (PLY) is a cholesterol-dependent cytolysin (CDC) produced by Streptococcus pneumoniae, the main cause of community-acquired pneumonia. We have applied a set of diverse molecular methodologies (PCR-derived PLY peptides, biopanning of a library of phage-displayed random nonapeptides, indirect ELISA and competition tests with soluble peptides) to achieve concordant complementary observations in order to obtain a fine epitope mapping of three mouse monoclonal antibodies (PLY-4, PLY-7 and PLY-8) for PLY. PLY-4 seems to recognise a conformation-dependent epitope with a core reactivity involving R232. The epitopes recognised by PLY-7 and PLY-8 are within the sequences (401)GQDLTAH(407) and (450)KRTISIWGT(458), respectively. PLY-7 also recognises suilysin (SLY), in which the homologous reactive amino acid stretch is (429)GVNLTSH(435). In a homology model of PLY with the crystal structure of perfringolysin O (PFO), R232 is part of a well-exposed contorted loop on the edge of the concave and convex faces of domain 1. The sequences reactive with PLY-7 and PLY-8 would conform one of the loops at the bottom of domain 4 and a beta strand of one of the two beta sheets of this domain, respectively. Western blot analyses carried out with anti-PLY rabbit IgG and polyclonal mouse serum identified stretches comprising residues 40-98, 199-248, 352-414 and 415-471 of PLY as immunogenic and antigenic; altogether with their recognition by the monoclonal antibodies herein considered, these results stress the immunological significance of domains 1 and 4 of the PLY molecule. PLY-4, PLY-7 and PLY-8 share the same Vkappa chain; this chain and that of the PLY-5 monoclonal antibody are essentially in germline configuration, whereas the VH regions of these monoclonals come from diverse gene segments and are mutated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941482     DOI: 10.1016/s0165-2478(03)00081-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  Oriented immobilization of anti-pneumolysin tagged recombinant antibody fragments.

Authors:  Maria del Mar Garcia-Suarez; Roberto Villaverde; Irene Gonzalez-Rodriguez; Fernando Vazquez; Francisco J Mendez
Journal:  Curr Microbiol       Date:  2009-03-28       Impact factor: 2.188

2.  Development of a single-gene, signature-tag-based approach in combination with alanine mutagenesis to identify listeriolysin O residues critical for the in vivo survival of Listeria monocytogenes.

Authors:  Jody A Melton-Witt; Susannah L McKay; Daniel A Portnoy
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

3.  Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis.

Authors:  Rebecca E LaFond; Barbara J Molini; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

4.  Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis.

Authors:  Johanna Jefferies; Leena Nieminen; Lea-Ann Kirkham; Calum Johnston; Andrew Smith; Tim J Mitchell
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

5.  Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.

Authors:  María del Mar García-Suárez; María Dolores Cima-Cabal; Noelia Flórez; Pilar García; Rafael Cernuda-Cernuda; Aurora Astudillo; Fernando Vázquez; Juan R De los Toyos; F Javier Méndez
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Insights into structure and activity of natural compound inhibitors of pneumolysin.

Authors:  Hongen Li; Xiaoran Zhao; Xuming Deng; Jianfeng Wang; Meng Song; Xiaodi Niu; Liping Peng
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

7.  Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.

Authors:  Els van Westen; Martien C M Poelen; Germie P J M van den Dobbelsteen; Eliud O Oloo; Martina M Ochs; Nynke Y Rots; Cecile A C M van Els
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

Review 8.  Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection.

Authors:  Tamara Escajadillo; Victor Nizet
Journal:  Toxins (Basel)       Date:  2018-12-17       Impact factor: 4.546

9.  Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity.

Authors:  Indre Kucinskaite-Kodze; Martynas Simanavicius; Justas Dapkunas; Milda Pleckaityte; Aurelija Zvirbliene
Journal:  Biomolecules       Date:  2020-07-08

10.  Matcha Green Tea Exhibits Bactericidal Activity against Streptococcus pneumoniae and Inhibits Functional Pneumolysin.

Authors:  Karin Sasagawa; Hisanori Domon; Rina Sakagami; Satoru Hirayama; Tomoki Maekawa; Toshihito Isono; Takumi Hiyoshi; Hikaru Tamura; Fumio Takizawa; Yoichi Fukushima; Koichi Tabeta; Yutaka Terao
Journal:  Antibiotics (Basel)       Date:  2021-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.